PlainRecalls
FDA Devices Moderate Class II Ongoing

Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.

Reported: August 4, 2021 Initiated: June 7, 2021 #Z-2135-2021

Product Description

Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.

Reason for Recall

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Details

Recalling Firm
Medtronic Vascular, Inc.
Units Affected
18 devices
Distribution
U.S.: GA, MA, MD, NY, SC, TX, WA, and WV O.U.S.: Argentina, Australia, Germany, Greece, Israel, Italy, Netherlands, Poland, South Africa, Spain, Switzerland and United Kingdom.
Location
Santa Rosa, CA

Frequently Asked Questions

What product was recalled?
Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.. Recalled by Medtronic Vascular, Inc.. Units affected: 18 devices.
Why was this product recalled?
During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 4, 2021. Severity: Moderate. Recall number: Z-2135-2021.